| Chad Beattie, MD | |
|
531 Faunce Corner Rd, Dartmouth, MA 02747-1242 | |
| (508) 996-3991 | |
| (508) 990-3218 |
| Full Name | Chad Beattie |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 16 Years |
| Location | 531 Faunce Corner Rd, Dartmouth, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790946176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | 237742 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southcoast Hospitals Group | Fall river, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steward Medical Group Inc | 2860688728 | 1404 |
News Archive
Rural/Metro Corporation, a leading provider of ambulance and private fire protection services, today announced that, pursuant to the terms of its previously announced tender offer and consent solicitation for its outstanding 9.875% Senior Subordinated Notes due 2015, holders of $121 million aggregate principal amount of the outstanding Notes (approximately 96.8%) have validly tendered their Notes and have validly delivered the requisite consents for the proposed amendments prior to the expiration of the consent date which was 5:00 pm, New York City time, on November 20, 2009.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Fox Chase Cancer Center researchers have discovered that low-oxygen regions in prostate tumors can be used to predict a rise in prostate-specific antigen (PSA) levels, a marker of tumor recurrence in prostate cancer.
The American Association for Pediatric Ophthalmology and Strabismus, the professional body for pediatric eye care, has issued revised guidelines for preschool vision screening based on new evidence.
› Verified 1 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821349317 PECOS PAC ID: 2860688728 Enrollment ID: O20130626000396 |
News Archive
Rural/Metro Corporation, a leading provider of ambulance and private fire protection services, today announced that, pursuant to the terms of its previously announced tender offer and consent solicitation for its outstanding 9.875% Senior Subordinated Notes due 2015, holders of $121 million aggregate principal amount of the outstanding Notes (approximately 96.8%) have validly tendered their Notes and have validly delivered the requisite consents for the proposed amendments prior to the expiration of the consent date which was 5:00 pm, New York City time, on November 20, 2009.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Fox Chase Cancer Center researchers have discovered that low-oxygen regions in prostate tumors can be used to predict a rise in prostate-specific antigen (PSA) levels, a marker of tumor recurrence in prostate cancer.
The American Association for Pediatric Ophthalmology and Strabismus, the professional body for pediatric eye care, has issued revised guidelines for preschool vision screening based on new evidence.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chad Beattie, MD 531 Faunce Corner Rd, Dartmouth, MA 02747-1242 Ph: (508) 996-3991 | Chad Beattie, MD 531 Faunce Corner Rd, Dartmouth, MA 02747-1242 Ph: (508) 996-3991 |
News Archive
Rural/Metro Corporation, a leading provider of ambulance and private fire protection services, today announced that, pursuant to the terms of its previously announced tender offer and consent solicitation for its outstanding 9.875% Senior Subordinated Notes due 2015, holders of $121 million aggregate principal amount of the outstanding Notes (approximately 96.8%) have validly tendered their Notes and have validly delivered the requisite consents for the proposed amendments prior to the expiration of the consent date which was 5:00 pm, New York City time, on November 20, 2009.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
Fox Chase Cancer Center researchers have discovered that low-oxygen regions in prostate tumors can be used to predict a rise in prostate-specific antigen (PSA) levels, a marker of tumor recurrence in prostate cancer.
The American Association for Pediatric Ophthalmology and Strabismus, the professional body for pediatric eye care, has issued revised guidelines for preschool vision screening based on new evidence.
› Verified 1 days ago
Dr. Robert John Caldas, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Dr. Debby Almeida, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Dr. Ryan Gates, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Dr. David R Clark, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Kimberly Lewis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Achilles Romualdo E Alcaraz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 | |
Eleni Rethimiotakis, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |